Skip to main content
Premium Trial:

Request an Annual Quote

Syapse to Provide Computational Support for Drug Repositioning and Development Alliance

Premium

Palo Alto, Calif.–based Syapse said this week that it semantic computing platform and application suite will be to develop GaugeRx, a web-based analytics and assessment tool that will use human health and disease information to support drug repositioning and development.

GaugeRx, which will be launched at the end of 2013, is being developed as part of a collaboration between Switzerland's EspeRare Foundation and the United States' Genetic Alliance.

The partners plan to build a tool that provides pharmaceutical companies among others with information that will help them use existing resources and prioritize programs that advance their drug research and development portfolios.

GaugeRx will incorporate data from the Genetic Alliance's Navigating the Ecosystem of Translational Science system which provides a drug development map, and from its Disease InfoSearch resource, a curated compendium of data on genetic conditions. It will use Syapse's platform to handle data and knowledge management, mining, and reporting.

The financial details of the agreement were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.